𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rationale for combination ketoconazole/ vitamin D treatment of prostate cancer

✍ Scribed by Donna M Peehl; Eugene Seto; David Feldman

Book ID
117263870
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
140 KB
Volume
58
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale for active vitamin D and analo
Rationale for active vitamin D and analogs in the treatment of osteoporosis
✍ Yasuho Nishii πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract In 1981, Chugai Pharmaceutical succeeded in marketing alfacalcidol, a prodrug of calcitriol, as a therapeutic agent for renal osteodystrophy. In 1983, Chugai succeeded in extending the application of alfacalcidol to the treatment of osteoporosis as well. Clinicians in Japan have accepte

Prostate cancer laterality as a rational
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer
✍ Vladimir Mouraviev; Janice M. Mayes; Leon Sun; John F. Madden; Judd W. Moul; Tho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Early detection of small‐volume prostate cancer (PCa) has led to the concept of focal therapy to treat PCa as an organ‐sparing, minimally invasive procedure. The authors sought to determine the frequency of unilateral cancers in the contemporary prostate‐specific antigen